RNA recognition motif-type RNA-binding domain containing proteins (RBDPs) participate in RNA metabolism including regulating mRNA stability, nuclear-cytoplasmic shuttling, and splicing. Rbm45 is an RBDP first cloned from rat brain and expressed spatiotemporally during rat neural development. More recently, RBM45 has been associated with pathological aggregates in the human neurological disorders amyotrophic lateral sclerosis, frontotemporal lobar degeneration, and Alzheimer's. Rbm45 and the neural developmental protein musashi-1 are in the same family of RDBPs and have similar expression patterns. In contrast to Musashi-1, which is upregulated during colorectal carcinogenesis, we found no association of RBM45 overexpression in human colon cancer tissue. In order to begin characterizing RNA-binding partners of Rbm45, we have successfully cloned and expressed 2 human RBM45 in an Intein fusion-protein expression system. Furthermore, to gain a better understanding of the molecular genetics and evolution of Rbm45, we used an in silico approach to analyze the gene structure of the human and mouse Rbm45 homologues and explored the evolutionary conservation of Rbm45 in metazoans. Human RBM45 and mouse Rbm45 span ~17 kb and 13 kb, respectively, and contain 10 exons, one of which is non-coding. Both genes have TATA-less promoters with an initiator and a GC-rich element. Downstream of exon 10, both homologues have canonical polyadenylation signals and an embryonic cytoplasmic polyadenylation element. Moreover, our data indicate Rbm45 is conserved across all metazoan taxa from sponges (phylum Porifera) to humans (phylum Chordata), portending a fundamental role in metazoan development.
Introduction

RNA recognition motif-type RNA (RRM)-binding domain (RBD) containing proteins
(RBDPs) have diverse cellular functions. RBDPs have been demonstrated to regulate the stability of target mRNAs (e.g. CUGBP2 [Mukhopadhyay et al., 2003 ], HuR, [Abe et al., 1996 ] , and Elav [Joseph et al., 1998 ]), the translatability of target mRNAs (e.g. musashi-1 Sureban et al., 2008 ] , Elav/Hu protein family [Antic et al., 1999; Chung et al., 1997; Okabe et al., 2001; Kasashima et al., 1999; Kawagishi et al., 2013] , and CUGBP2 [Anant et al., 2001; Mukhopadhyay, 2003; Sureban et al., 2007] ), or both, in various tissues including neural and digestive (e.g. CUGBP2; Anant et al., 2004; Mukhopadhyay et al., 2003) . Besides the canonical function of RNA binding, several RBDPs have been identified as being multifunctional proteins participating in RNA-mediated protein:protein interactions (A1CF [Blanc et al., 2001a [Blanc et al., , 2005 [Blanc et al., , 2007 Galloway et al., 2010; Henderson et al., 2001; Mehta and Driscoll, 2002] , Syncrip (GRY-RBP) [Blanc et al., 2001b; Lau et al., 2002] , and CUGBP2 [Anant et al., 2001; Mukhopadhyay et al., 2003 ] ) or RNA-independent protein:protein interactions (e.g. neuronal proteins TDP-43 and FUS, reviewed in Ugras and Shorter, 2012) .
RNA-binding motif protein 45 (Rbm45), also known as developmentally regulated RNAbinding protein 1(Drbp1), was first identified as a novel RNA-binding protein through the screening of a rat cerebral expression library with polyclonal antibody against consensus RRM sequences. Rbm45 has three (Li et al., 2015b; Mashiko et al., 2016) or four canonical RBDs (Tamada et al., 2002 ; HomoloGene, https://www.ncbi.nlm.nih.gov/homologene/?term=Rbm45 [accessed 11.15.2017] ) and is expressed in a spatiotemporal manner in developing rat brain, with highest expression, as measured by mRNA accumulation, occurring between embryonic days 12 to 16. There is a subsequent decline in expression of Rbm45 during late embryonic development that extends into adulthood as neuronal precursor cells differentiate (Tamada et al., 2002) .
Additionally, Rbm45 has been demonstrated to be upregulated after spinal cord injury in an opossum neonatal model of neuronal repair (Mladinic et al., 2010) . Subsequent work from Robert Bowser's lab group (2012, 2015a, 2015b, 2016) and Hitoshi Endo's lab (2016) strongly associate RBM45 aggregation in the pathogenesis of the destructive neurodegenerative disorders amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration with TDP-43 inclusions (FTLD-TDP). Furthermore, mouse Rbm45 demonstrates strong association with aberrant prepulse inhibition, a measure of sensorimotor gating (startle reflex), an endophenotypic marker for neuropsychiatric disorders (Sittig et al., 2016) . These studies implicate Rbm45 in neurogenesis, neuronal pathology, and neuronal repair. Despite the work of these groups, little is known about how Rbm45 accumulation contributes to the progression of neurodegenerative diseases, neural development, or neural maintenance.
RBDPs are typically multifunctional and act both in the nucleus and cytoplasm, influencing transcription, RNA splicing, RNA export, translation, and transport of mRNAs (reviewed in Ling et al., 2013) . Current research on ALS and FTLD-TDP (Li et al., 2015b; Mashiko et al., 2016) indicates RBM45 shares some of these functions (e.g. cytoplasmic-nuclear shuttling, homo-oligomerization, and heterodimerization with proteins involved in splicing), but also interacts with other RNA-binding proteins to modulate responses to oxidative stress and extracellular signaling (Li et al., 2016) . In this report, we analyze the genomic structure, regulatory elements, gene expression, and evolutionary history of Rbm45 to gain an understanding of its role in metazoan development.
Experimental Procedures
Genomic Analysis
Rbm45 nucleotide and protein sequences were obtained from the National Center for Biotechnology Information (NCBI; https://www.ncbi.nlm.nih.gov/). Rbm45 orthologues were identified using the BLAST algorithm with Mus musculus (mouse; strain: Balb/C) Rbm45 cDNA, accession number (no.) AB036992.1 (Tamada et al., 2002) as the query sequence and retrieved from GenBank (https://www.ncbi.nlm.nih.gov/). The following accession nos. were utilized in this study: mouse (strain: C57BL/6J) Rbm45 genomic nucleotide (nt) sequence (NT039207.6), Homo sapiens (human) Rbm45 genomic nt sequence (NT005403), human 
Quantitative Reverse Transcription-Polymerase Chain Reaction (qRT-PCR) Amplification
Analysis of Human and Mouse Rbm45
RNA was extracted from normal adjacent and tumor tissue from human colon using TRIreagent (Sigma-Aldrich) as described by the manufacturer. Total RNA for reverse transcription was prepared as described by Henderson and coworkers (2001) , with the following modifications. Briefly, aliquots of total RNA (10 μg) were treated with 2 units RQ1 DNase (Promega) at 37˚C for 1 h in 100 μL 40 mM Tris-HCl pH 7.6, 6 mM MgCl2, 10 mM NaCl, 40 U RNasin (Promega Mouse Rbm45 cDNA was cloned using a nested PCR approach. ssDNA was produced from mouse strain C57Bl/6J brain total RNA, purified with TRIzol Reagent (Invitrogen), using the gene specific primer mRbm45R (antisense; 5ʹ-cagtcagtcagctgaggattatgtc-3ʹ) and SuperScript III RNase H -Reverse Transcriptase (Invitrogen) as described by the manufacturer. The Rbm45 ssDNA was used as a template to amplify a full-length cDNA, flanked by non-coding DNA, using AccuPrime Pfx DNA polymerase (Invitrogen) and primers mRbm45F (sense; 5ʹ-agaacctgccgggtgaaca-3ʹ) and mRbm45R under the following cycling conditions: Initial heat denaturation at 95˚C for 2 min, then 30 cycles of 95˚C for 15 sec, annealing at 55˚C for 30 sec, and extension at 68˚C for 1 min 30 sec. A final extension of 10 min at 72˚C was used for the last cycle. The 1542 bp amplicon was subcloned into pSC-B using the StrataClone Ultra Blunt PCR Cloning Kit (Agilent) to create pJH1 and sequenced on both strands. The mouse Rbm45 coding sequence was then amplified from pJH1 using primers mRbm45IntF (sense; 5ʹ-ggt ggt cat atg gac gac gcc ggc ggc tt-3ʹ; NdeI restriction site underlined, AA2 double underlined) and mRbm45IntR (antisense; 5ʹ-gta agt tct ctg cct ctt ttt-3ʹ; AA476 double underlined) under the above cycling conditions. The 1455 bp amplicon was cleaved with SapI and cloned into pTYB2
(New England Biolabs) digested with NdeI and SmaI creating a mouse Rbm45 C-terminal Intein fusion protein. Expression and purification of the fusion protein was conducted in ER2566 E. coli cells as previously described (Blanc et al., 2001b) (Strachan et al., 2015) . Currently (10.21.2017) , no information exists as to whether the human RBM45 pseudogene is a retrogene. Nevertheless, the four RBDs described in the rat Rbm45 cDNA cloned by Endo and colleagues (Tamada et al., 2002) are the products of exons 1, 2-3, 4-6, and 8-9, respectively (Fig. 1A ).
Approximately 243 nt of sequence 5ʹ of exon 1 was analyzed for putative promoter elements. The core promoter was found to be TATA-less, a common occurrence in genes that regulate development in metazoans. Confounding the identification of potential promoter elements, both in human and mouse, is the observation that TATA-less promoters can potentially have many different start sites ranging from 20 to 200 bp upstream of the 5ʹ-UTR (Weaver, 2012) . Nevertheless, we identified putative core promoter elements for the RBM45 gene including an initiator element (INR) conforming roughly to the canonical PyPyAN(T/A)PyPy (where Py is any pyrimidine, e.g. thymine or cytosine, and N is any nucleotide) which would be predicted to encompass the transcription start site. INR sequences are highly degenerate (Weaver, 2012) and our putative INR matches 4 of 7 of the canonical nucleotides. Confirming this region as the transcription start site would require performing primer extension analysis , for example, but is beyond the scope of this report. In addition to the INR, a CpG island, a proximal promoter element, was identified suggesting possible epigenetic regulation of RBM45 via cytosine methylation (Deaton and Bird, 2011) . Both elements have been reported (Weaver, 2012) to be important for transcription initiation in the absence of a TATA box. Interestingly, a downstream promoter element (DPE) was not identified in the human RBM45 exon 1 5ʹ-untranslated region (5ʹ-UTR; Fig. 1B ). DPEs are typically found +28 to +32 relative to the transcription start site and are a common feature in TATA-less promoters. In contrast, the related mouse Rbm45 contains a DPE in its 5ʹ-UTR (Fig. 2B) . However, presence of a DPE in TATA-less promoters is not sacrosanct as eukaryotic promoters are highly modular (Weaver, 2012) .
Messenger RNA (mRNA) molecules often possess a poly(A) tail of approximately 250 adenosine residues. The poly(A) tail acts to increase the stability (Huez et al., 1974) and translatability (Munroe and Jacobson, 1990 ) of mRNA; additionally, the poly(A) tail plays a role in the transport of mature mRNA molecules from the nucleus to the cytoplasm (Eckner et al., 1991) . Approximately 889 nt of genomic DNA (gDNA) downstream of RBM45 exon 10 were examined for putative polyadenylation signal elements, revealing the presence of an embryonic cytoplasmic polyadenylation signal ( Fig. 1C ; Fox et al., 1989) upstream of a canonical polyadenylation consensus signal (PACS; Fitzgerald and Shenk, 1981) . Downstream of the PACS is a polyadenylation cleavage site (PCS) and a U-rich motif (Fig. 1C) . Typically, the Urich motif (T-rich in gDNA) is immediately preceded by a GU-rich motif (GT-rich in gDNA) but is not required for polyadenylation; albeit, polyadenylation is suboptimal in the absence of a GUrich motif (Gil and Proudfoot, 1987; Weill et al., 2012) .
All of the RBM45 intron-exon junctions were analyzed and conformed to the canonical consensus for splice donor and splice acceptor sites (Breathnach and Chambon, 1981) Analysis of the cDNA sequence (XM_005246287.4) of the predicted RBM45 X2 isoform shows it is derived by use of a cryptic splice acceptor site on the 5ʹ-end of exon 5, resulting in an inframe 2 AA insertion predicted to encode a 476AA protein. Neither RBM45 isoform X1 or X2 is known to be physiologically relevant. 
Mouse Rbm45: Genomic Organization and Structure
As with the human sequence, above, we queried (Spring 2007) the nr/nt collection, using BLASTn, with the mouse cDNA sequence revealing the exon/intron junctions on the mouse genomic sequence. Similar to human, the chromosomal locus containing the Mus musculus (mouse) Rbm45 gene spans approximately 13 kb and contains 10 exons ( Fig. 2A) (Tamada et al., 2002) are the products of exons 1, 2-3, 4-6, and 8-9, respectively ( Fig.   2A ).
Like human RBM45, analysis of mouse Rbm45 sequence 5ʹ of exon 1 (approximately 198 nt) reveals that the promoter is TATA-less and contains a putative degenerate consensus (5 of 7 nt match) INR encompassing a predicted transcription start site (compare Fig. 2B to Fig. 1B) . In contrast to human RBM45 (Fig. 1B) , mouse Rbm45 contains a sequence with 4 of 7 nt matches to the consensus ([A/G]G[A/T]CGTG) DPE sequence at +28 to +32 relative to the predicted transcriptional start site, and has a GC-rich proximal promoter element in the form of a canonical GC-box (Fig. 2B) . GC-boxes have been demonstrated to enhance transcription of TATA-less promoters by binding the transcription factor Sp1 (Goodrich et al., 1996) .
As in human RBM45, analysis of approximately 889 nt of gDNA downstream of mouse
Rbm45 exon 10 for putative polyadenylation signal elements (Fig. 2C ) revealed an embryonic cytoplasmic polyadenylation consensus signal upstream of a PACS. Downstream of the PACS is a PCS and, in contrast to human RBM45, both a canonical GU-and U-rich motif. The presence of both of these elements suggests that mouse Rbm45 may be more efficiently polyadenylated than human RBM45, thereby increasing expression of Rbm45 protein (Gil and Proudfoot, 1987) .
This assertion would need to be confirmed empirically, but is a reasonable hypothesis given the sequence data. In both the human and mouse Rbm45 genes, the presence of an embryonic cytoplasmic polyadenylation consensus signal correlates with the observation that highest expression of RBM45/Rbm45 occurs during (neural) development, at least in the rat and mouse (Tamada et al., 2002; McKee et al., 2005) . Analysis of human fetal brain tissue by qRT-PCR would give some indication of the developmental regulation of human RBM45 mRNA levels; unfortunately, such a study is beyond the capabilities of our laboratory.
All of the mouse Rbm45 intron-exon junctions were analyzed and conformed to the canonical consensus splice donor and splice acceptor sites (Breathnach and Chambon, 1981) as enumerated in Table 2 . Sequence analysis of cDNA clones from RT-PCR and database interrogation (https://blast.ncbi.nlm.nih.gov/Blast.cgi; data not shown) did not reveal splice variants, consistent with previous analyses (Tamada et al., 2002; McKee et al., 2005) . 
Expression of human and mouse Rbm45 orthologues
Many RNA-binding proteins have been shown to be directly involved in tumorigenesis, including APOBEC-1 (Blanc et al., 2007) , CUGBP2 (Mukhopadhyay et al., 2003) , Hel-N1, HuR, and musashi-1 (Sureban et al., 2007 (Sureban et al., , 2008 . Moreover, CUGBP2, Hel-N1, HuR, and Musashi-1 are RDBPs similar in structure to Rbm45. Additionally, musashi-1 and Rbm45 are both expressed in differentiated neural cells and are involved in neural development (reviewed in Tamada et al., 2002) . Intriguingly, musashi-1 has been shown to be upregulated in colon cancer and knockdown of its expression inhibits tumorigenesis (Sureban et al., 2008) , properties expected of an oncogene (Hardin et al., 2012) . Because of the similarities in both structure and expression of musashi-1 and Rbm45, coupled with the known property of cancer cells to have a dedifferentiated (embryonic-like) phenotype (Gilbert and Barresi, 2016) , we hypothesized that expression of human RBM45 would be dysregulated during colonic tumorigenesis.
Consequently, qRT-PCR on seven paired samples of human normal and cancerous colon tissue was performed. Unlike musashi-1, no change in RBM45 expression at the mRNA level was detected (P = 0.867, Fig. 3A) ; unfortunately, not enough tissue sample remained to determine protein levels. Had the resources been available, analyses of the expression of RBM45 in developmental cancers, such as teratocarcinoma (tumor of stem cells; Gilbert and Barresi, 2016) and the two most common pediatric brain tumors, brain stem glioma and astrocytoma, two very aggressive cancers having a high rate of mortality and morbidity (Wrensch et al., 2002) , may have illuminated a neural specific expression pathway with the potential to better understand how these tumors progress.
Concomitant with analysis of the tumor samples, we also examined the expression of mouse Rbm45 in adult tissue including: brain, heart, spleen, lung, skeletal muscle, kidney, small intestinal enterocytes, colon, and liver. Our data (Fig. 3B) demonstrate that expression was highest in the brain with skeletal muscle and colon having 10-fold lower expression compared to brain; heart, spleen, lung, kidney, small intestinal enterocytes, and liver showed approximately three-to six-fold lower expression compared to brain. These data confirm and extend the work of The graph shows the ratio of human RBM45 to the internal control, 18S rRNA, in human normal adjacent (Normal) and colorectal cancer (Tumor) tissue. RBM45/18S rRNA levels in normal tissue were set to one. There is no significant difference in RBM45 mRNA levels in tumor vs. normal tissue (P = 0.867, two-tailed t test; n = 7 matched normal and tumor samples). (B) Adult mouse brain tissue expresses the highest levels of Rbm45 mRNA. Survey of adult mouse Rbm45 mRNA tissue levels. Rbm45/18S rRNA levels in brain were set to one. Rbm45 mRNA levels are reduced 10-fold in skeletal muscle (Sk. Muscle) and Colon and reduced 2.4-to 5.88-fold in Heart, Spleen, Lung, Kidney, Enterocyte (epithelial cells of the small intestine), and Liver. The 2 -ΔΔCt values are labelled above each tissue.
A.
B.
Recombinant expression and purification of human and mouse Rbm45
To begin the process of identifying potential RNA-binding partners, we cloned the human RBM45 and mouse Rbm45 cDNAs, respectively, to create Intein fusion proteins. The
Intein moiety can be cleaved from the fusion protein during on-column purification to release the Rbm45 protein. Both human RBM45 and mouse Rbm45 were cloned so that the Intein protein is fused to the C-terminus.
Human RBM45 was efficiently expressed as a RBM45/C-terminal Intein fusion protein.
Analysis of expressed RBM45-Intein protein by SDS-PAGE revealed a molecular mass of ~80 kDa (53 kDa from RBM45 + 28 kDa from Intein), as expected. The recombinant protein was purified over a chitin column, subjected to on-column cleavage, and the eluent analyzed by SDS-PAGE revealing an ~53 kDa protein at ~95% purity (data not shown). The molecular mass of human RBM45 confirms that of Tamada and colleagues (2002) . Having the ability to express large amounts of human RBM45 will allow us to identify putative RNA-(GACGAC motif; Ray et al., 2013) and protein-binding partners in mouse brain extracts.
Expression of recombinant mouse Rbm45/C-terminal Intein fusion protein was poor.
Expression optimization was carried out at 15˚C, 25˚C, or 30˚C using a concentration gradient of 0.3, 0.4, or 0.5 mM of the inducer, IPTG. Only cells induced with 0.5 mM IPTG and incubated at 15˚C produced detectable protein by SDS-PAGE analysis (data not shown). The fusion protein had the expected molecular mass of ~80 kDa; however, expression was estimated to be 100-fold showed orthologues across all metazoan taxa: animals that develop from only a blastula (one germ layer, no gastrulation), phylum Porifera (sponges); diploblasts (two germ layers), phylum Cnidaria (hydra); lophotrochozoan protostomia, phyla Mollusca (cephalopods: e.g. octopus), and Annelida (segmented worms); ecdysozoan protostomia, phylum Arthropoda (insects); and the deuterostomia phyla Echinodermata (sea urchin) and Chordata (Subphylum vertebrata: e.g. humans) (Hickman et al., 2011; see Brusca [2016] for an alternative view of the phylogeny). Our analysis of Rbm45 orthologues was confined to ten vertebrate species within classes Actinopterygii (ray-finned fishes), Amphibia, Reptilia (Aves), and Mammalia, including the important molecular genetic and developmental model systems Danio rerio (zebrafish), Xenopus A similar examination using amino acid sequences from the same Rbm45 orthologues (Fig. 5 ) exhibit an almost identical phylogram (Fig. 5A ) to that produced using nucleotide sequences (Fig. 4A) , with the only difference being that mouse is not grouped with the other GCTCACAAGAATATTTGTGATGATCCCGAAAACATTCACTGAGGATGATT 534 ** ** **** ***** ***** ** ** * * ** ** ** ** placentals (paraphyletic). However, other phylograms generated (not shown), illustrated the "correct" taxonomical relationships; we chose to use an unbiased methodology (see Experimental Procedures). Multiple sequence alignment of Rbm45 protein from 10 vertebrates demonstrates 65% conservation at the protein level (Fig. 5B, Supplementary Fig. 2 ). Since mouse is an important genetic model for understanding gene function in mammals, pairwise alignment of amino acid sequences from mouse and human was carried out revealing 93.5%
conservation. In like manner, rat is often used as a physiological model for human metabolic pathways; pairwise alignment of mouse and rat Rbm45 showed 100% identity at the amino acid level (data not shown). Additionally, Tamada and coworkers (2002) reported 91.6% identity between rat and human Rbm45 protein. Unsurprisingly, orangutan, chimpanzee, and human, sharing a common ancestor (Darwin, 1874; Finstermeier et al., 2013) , form the least inclusive monophyletic grouping in the phylogram produced using Rbm45 amino acid sequence (Fig. 5A) , with chimpanzee and human (subfamily Homininae, tribe Hominini [Gray, 1825; Hall and Hallgrimsson, 2014] ) being the least inclusive monophyletic grouping in the phylogram generated using Rbm45 nt sequence (Fig. 4A ). The phylograms in Figures 4A and 5A closely mimic the current understanding of tetrapod evolution (Amemiya et al., 2013) , supporting the molecular taxonomic relationship we observed.
Considering our molecular phylogeny data and that sponges don't have a nervous system, but retain a neural toolkit of genes (Leys, 2015) , including an Rbm45 orthologue, it is tempting to speculate that these data suggest Rbm45 exhibits deep homology (Zimmer and Emlen, 2016) , a fundamental, evolutionarily-conserved, function in (neuronal) development of metazoans.
